ANNX
Annexon, Inc.
NASDAQ · Healthcare · Biotechnology · US
$4.87
+0.62%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-108.9%
Return on equity
-82.4%
Return on assets
-99.9%
Return on invested capital
0.00x
Asset turnover
-$193.0M
Cash from operations
$1.10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026